- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Burning Rock Biotech Ltd is a diagnostics & research business based in the US. Burning Rock Biotech Ltd shares (BNR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.50 – a decrease of 7.14% over the previous week. Burning Rock Biotech Ltd employs 786 staff and has a trailing 12-month revenue of around $509.8 million.
What's in this guide?
Our top picks for where to buy Burning Rock Biotech Ltd stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Burning Rock Biotech Ltd stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BNR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Burning Rock Biotech Ltd stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Burning Rock Biotech Ltd stock price (NASDAQ: BNR)
Use our graph to track the performance of BNR stocks over time.Burning Rock Biotech Ltd shares at a glance
Information last updated 2024-12-19.
| Latest market close | $6.50 |
|---|---|
| 52-week range | $2.62 - $9.99 |
| 50-day moving average | $4.36 |
| 200-day moving average | $6.03 |
| Wall St. target price | $4.03 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-5.71 |
Is it a good time to buy Burning Rock Biotech Ltd stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Burning Rock Biotech Ltd price performance over time
Historical closes compared with the close of $6.5 from 2024-12-23
| 1 week (2024-12-18) | -7.14% |
|---|---|
| 1 month (2024-11-25) | 16.91% |
| 3 months (2024-09-25) | 128.07% |
| 6 months (2024-06-25) | -4.41% |
| 1 year (2023-12-22) | 802.78% |
|---|---|
| 2 years (2022-12-23) | -68.75% |
| 3 years (2021-12-23) | 105 |
| 5 years (2019-12-21) | N/A |
Burning Rock Biotech Ltd financials
| Revenue TTM | $509.8 million |
|---|---|
| Gross profit TTM | $380 million |
| Return on assets TTM | -30.91% |
| Return on equity TTM | -68.89% |
| Profit margin | -111.18% |
| Book value | $75.01 |
| Market Capitalization | $71.8 million |
TTM: trailing 12 months
Burning Rock Biotech Ltd share dividends
We're not expecting Burning Rock Biotech Ltd to pay a dividend over the next 12 months.
Have Burning Rock Biotech Ltd's shares ever split?
Burning Rock Biotech Ltd's shares were split on a 1:10 basis on 14 May 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Burning Rock Biotech Ltd shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Burning Rock Biotech Ltd shares which in turn could have impacted Burning Rock Biotech Ltd's share price.
Burning Rock Biotech Ltd share price volatility
Over the last 12 months, Burning Rock Biotech Ltd's shares have ranged in value from as little as $2.62 up to $9.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Burning Rock Biotech Ltd's is 0.145. This would suggest that Burning Rock Biotech Ltd's shares are less volatile than average (for this exchange).
Burning Rock Biotech Ltd overview
Burning Rock Biotech Limited primarily develops and sells cancer therapy selection tests in the People's Republic of China. It operates through three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. The company also provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients, as well as Magnis BR-customized version of its principal products. In addition, it offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited has development and commercialization agreement with Myriad Genetics, Inc.
Frequently asked questions
nullWhat percentage of Burning Rock Biotech Ltd is owned by insiders or institutions?
Currently 0.039% of Burning Rock Biotech Ltd shares are held by insiders and 60.946% by institutions. How many people work for Burning Rock Biotech Ltd?
Latest data suggests 786 work at Burning Rock Biotech Ltd. When does the fiscal year end for Burning Rock Biotech Ltd?
Burning Rock Biotech Ltd's fiscal year ends in December. Where is Burning Rock Biotech Ltd based?
Burning Rock Biotech Ltd's address is: No. 5, Xingdao Ring Road North, Guangzhou, China, 510005 What is Burning Rock Biotech Ltd's ISIN number?
Burning Rock Biotech Ltd's international securities identification number is: US12233L1070
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question